Dear Friends and Colleagues,
GHS 2023 will be delivered as a hybrid meeting, offering you the opportunity to meet in person in the beautiful capital city of Paris, France, or alternatively from the comfort of your office/home's virtual setting. The 2023 edition will feature a unique interdisciplinary Summit designed to share the latest developments in all aspects of liver diseases, including viral hepatitis, non-alcoholic fatty liver disease, hepatocellular carcinoma, and much more. It will encompass the continuum of research from basic science to clinical research and public health applications.
This event will be as much a networking event as a cutting-edge research conference, featuring dedicated tracks for health practitioners and inspiring workshops for those working in the liver and hepatitis space, where renown speakers will highlight the most exciting recent results in the field and provide perspectives for research and patient management. The multidisciplinary focus for all areas of interest will include basic science, translational research, the development of novel diagnostic tools and therapies, and approaches to control and eliminate liver diseases as public health threats.
In addition to full congress access, please visit the GHS 2023 website for an overview of virtual and sponsor pass rates. It will be our pleasure to welcome you to Paris for this historic scientific meeting.
With kind regards,
Prof. Jean-Michel Pawlotsky, MD, PhD
Co-Chair, GHS 2023
Prof. Fabien Zoulim, MD, PhD
Co-Chair, GHS 2023
